The results of the current study demonstrate that the HRPE cells express the reduced-folate transporter that mediates the cellular uptake of N5 methyltetrahydrofolate, the predominant form of folate in blood.
|Cell lines||HRPE cells|
|Preparation method||One milliliter of a hypotonic medium (10 mM Tris-HCl buffer, pH 8) containing 1 μM unlabeled N5-methyltetrahydrofolate was added to each well, and die cells were lysed by freezing and thawing.|
|Incubation time||2 h|
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
|Solubility||10 mM in DMSO|
Methyltetrahydrofolate:corrinoid/iron-sulfur protein methyltransferase (MeTr): protonation state of the ligand and active-site residues.
Alonso H, et al. J Phys Chem B. 2009 Nov 5;113(44):14787-96. PMID: 19827815.
Characterization of N5-methyltetrahydrofolate uptake in cultured human retinal pigment epithelial cells.
Huang W, et al. Invest Ophthalmol Vis Sci. 1997 Jul;38(8):1578-87. PMID: 9224286.
AM-0902 is a potent, selective antagonist of TRPA1 with IC50s of 71 and 131 nM for rTRPA1 and hTRPA1, respectively.
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
BMS-986205 is a selective indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor.
VU6005649 is a CNS penetrant mGlu7/8 receptor agonist with EC50s of 0.65 μM and 2.6 μM for mGlu7 receptor and mGlu8 receptor, respectively.
TLR7-agonist-1 is a potent and selective Toll-like Receptor 7 (TLR7) agonist with a LEC of 0.4 μM.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.